Literature DB >> 27669125

Effect of extremes of body weight on drug level in patient treated with standard dose of rivaroxaban for venous thromboembolism; real life experience.

Drj Arachchillage1, R Reynolds2, T Devey2, R Maclean2, S Kitchen2, J J van Veen2.   

Abstract

Entities:  

Keywords:  Extremes of body weight; Rivaroxaban; Safety; Treatment outcome; Venous thromboembolism

Mesh：

Substances：

Year:  2016        PMID： 27669125     DOI： 10.1016/j.thromres.2016.09.010

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  2 in total

1.  Safety and efficacy of direct oral anticoagulants across body mass index groups in patients with venous thromboembolism: a retrospective cohort design.

Authors:  Rachael M Cardinal; Frank D'Amico; Alyssa D'Addezio; Kaylee Dakers; Gregory Castelli
Journal:  J Thromb Thrombolysis       Date:  2021-01-02       Impact factor: 2.300

2.  The impact of body weight on rivaroxaban pharmacokinetics.

Authors:  Sarah J Barsam; Jignesh P Patel; Lara N Roberts; Venu Kavarthapu; Raj K Patel; Bruce Green; Roopen Arya
Journal:  Res Pract Thromb Haemost       Date:  2017-10-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.